Regulated Bioanalysis: PK, PD & Soluble Biomarkers
Regulated Bioanalysis: PK, PD & Soluble Biomarkers
Sensitive, robust assay development, validation, and sample testing across all biological matrices.
Pharmacokinetics (PK):
Total and free drug quantification using advanced ligand-binding (ELISA, electrochemiluminescence) and immunoassay platforms.
Pharmacodynamics (PD):
Quantitative measurement of circulating target proteins, ligand engagement, and downstream signaling markers.
Multiplex Biomarker Panels:
High-sensitivity cytokine, chemokine, and soluble checkpoint profiling (e.g., sPD-1, sCTLA-4, sLAG-3) in serum, plasma, and CSF.
Liquid Biopsy & Circulating Markers:
dPCR-based circulating cell-free DNA (cfDNA) analysis and extracellular vesicle (exosome) isolation and characterization.
